Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22Prostatic Neoplasms 11Osteoporosis 8Vitamin D Deficiency 7Polycystic Ovary Syndrome 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Colonic Neoplasms 5Neoplasms 4Obesity 3Neoplasm Metastasis 3Lung Neoplasms 3Inflammation 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Bone Diseases, Metabolic 3Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Leukemia 2Leiomyoma 2Giant Cell Tumor of Bone 2Gastrointestinal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Bone Diseases 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 5Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Surveys and Questionnaires 2Sugars 2Resistance Training 2Preoperative Exercise 2Observation 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Cholecalciferol 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulin Resistance × Vitamin D × Clear all
NCT00907153 2017-12-19

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

Milton S. Hershey Medical Center

Phase 1/2 Completed
36 enrolled 44 charts

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡